<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Intra-bone cord blood transplantation &#8211; the new clinical route to enhance engraftment</title>
	<atom:link href="http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/feed/" rel="self" type="application/rss+xml" />
	<link>http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/</link>
	<description>Blood Stem Cell &#38; Cell Therapy Trends</description>
	<lastBuildDate>Fri, 20 Jan 2012 01:41:14 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Alex</title>
		<link>http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/#comment-8962</link>
		<dc:creator>Alex</dc:creator>
		<pubDate>Sun, 21 Sep 2008 18:35:09 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/#comment-8962</guid>
		<description>engraftment in both ways of delivery (iv or intra-bone) should be very high, because of body irradiation or myeloablative regimen of chemotherapy. The targeting difference is &quot;time of engraftment&quot; or how soon we can see donor&#039;s cells in bloodstream. So compare with iv route, intra-bone seem like give a little bit faster engraftment for neutrophils (23 days median) and platelets (36 days median). 

Even you can accept that you deliver HSC directly to the niche, you really don&#039;t know is this true or not, because you can&#039;t measure (visualize) it so far. Even so, a lot of donor&#039;s cells injected into the bone goes directly to the bloodstream and travel around the body because bone cavity is highly vascularized.</description>
		<content:encoded><![CDATA[<p>engraftment in both ways of delivery (iv or intra-bone) should be very high, because of body irradiation or myeloablative regimen of chemotherapy. The targeting difference is &#8220;time of engraftment&#8221; or how soon we can see donor&#8217;s cells in bloodstream. So compare with iv route, intra-bone seem like give a little bit faster engraftment for neutrophils (23 days median) and platelets (36 days median). </p>
<p>Even you can accept that you deliver HSC directly to the niche, you really don&#8217;t know is this true or not, because you can&#8217;t measure (visualize) it so far. Even so, a lot of donor&#8217;s cells injected into the bone goes directly to the bloodstream and travel around the body because bone cavity is highly vascularized.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: JWS</title>
		<link>http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/#comment-8785</link>
		<dc:creator>JWS</dc:creator>
		<pubDate>Fri, 19 Sep 2008 18:13:54 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/2008/09/19/intra-bone-cord-blood-transplantation-the-new-clinical-route-to-enhance-engraftment/#comment-8785</guid>
		<description>Good diagram - didn&#039;t know where people actually inject. I was hoping something very high engraftment rate though - why is it still not even close to 100% success rate after cells are directly injected into niche?</description>
		<content:encoded><![CDATA[<p>Good diagram &#8211; didn&#8217;t know where people actually inject. I was hoping something very high engraftment rate though &#8211; why is it still not even close to 100% success rate after cells are directly injected into niche?</p>
]]></content:encoded>
	</item>
</channel>
</rss>

